Reticulate acropigmentation of Kitamura is now reported from all over the world. Additional features are being readily recognized. Our cases had pigmentation and pits on the dorsa of the distal phalanges of the fingers and toes – the classical features – as well as widely distributed pits on the palms, palmar aspect and sides of the fingers. The involvement in our cases was more pronounced than in the previously reported ones.

Griffiths WAD: Reticulate acropigmentation of Kitamura. Br J Dermatol 1976;95:437–443.
Bajaj AK, Gupta SC: Reticulate acropigmentation of Kitamura. Dermatologica 1984;164: 247–249.
Sharma R, Sharma SC, Radotra BD, Kaur S: Reticulate acropigmentation of Kitamura. Clin Exp Dermatol 1989;14:302–303.
Takahashi S, Maie O, Murai H: Acropigmentatio reticularis (Kitamura) and acropigmentatio reticularis inversa; in XVI Congressus Internationalis Dermatologiae, Tokyo 1982: Case Presentations. Tokyo, University of Tokyo Press, 1982, pp 137–138.
Lestringant GG, Aal GA, Frossard PM, Qayed K: Reticulate acropigmentation of Kitamura: Pigment specks and pits at unusual sites. Br J Dermatol 1994;131:137–139.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.